Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Dieamant, Débora C ^a   Bonon, Sandra H A ^a   Peres, Renata M B ^a   Costa, Claudia R C ^a   Albuquerque, Dúlcinéia M ^a   Miranda, Eliana C M ^a   Aranha, Francisco J P ^a   Oliveira Duarte, Gislaine ^a   Fernandes, Virginio C A ^a   De Souza, Carmino A ^a   Costa, Sandra C B ^a   Vigorito, Afonso C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Antigenemia; CMV genotyping; GVHD; Nested PCR; qPCR; RFLP

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; IMMUNOGLOBULIN G; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BRAZIL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; GASTROINTESTINAL DISEASE; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RECIPIENT; VIRUS LOAD;

EID: 84880030722     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-310     Document Type: Article

References (51)

1. Allice T, Cerruti F, Pittaluga F, et al. Evalution of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp 65-antigen test in guiding pre-emptive antiviral treatment. J Virol Methods 2008, 148:9-16. 10.1016/j.jviromet.2007.10.006, 18045702.
2. Cranage MP, Kouzarides T, Bankier AT, Satchwell S, Weston K, Tomlinson P, et al. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccine virus. Eur Mol Biol Orgn J 1986, 5:3057-3063.
3. Navarro D, Paz P, Tugizov S, Topp K, La Vail J, Pereira L. Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells. Virology 1993, 197:143-158. 10.1006/viro.1993.1575, 7692667.
4. Hopkins JI, Fiander AN, Evans AS, Delchambre M, Gheysen K, Borysiewicz LK. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. J Med Virol 1996, 49:124-131. 10.1002/(SICI)1096-9071(199606)49:2<124::AID-JMV9>3.0.CO;2-7, 8991935.
5. Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1991, 163:1229-1234. 10.1093/infdis/163.6.1229, 1709960.
6. Sarcinella L, Mazzulli T, Willey B, et al. Cytomegalovirus glycoprotein B genotype does not correlate with outcomes in liver transplant patients. J Clin Virol 2002, 24:99-105. 10.1016/S1386-6532(01)00238-4, 11744434.
7. Fries BC, Chou S, Boeckh M, et al. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994, 169:769-774. 10.1093/infdis/169.4.769, 8133090.
8. Meyer-Koning U, Volgelberg C, Bongarts A, et al. Glycoprotein B genotype correlates whit cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998, 55:75-81. 10.1002/(SICI)1096-9071(199805)55:1<75::AID-JMV12>3.0.CO;2-Z, 9580889.
9. Meyer-Koning U, Haberland M, von LD, et al. Intragenic vsriability of human cytomegalovirus glycoprotein B in clinical strains. J Infect Dis 1998, 177:1162-1669. 10.1086/515262, 9592998.
10. Sinzger C, Schmidt K, Knapp J, et al. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J Gen Virol 1999, 80:2867-2877.
11. Chou S. Comparative analysis of sequence variation in gp116 ang gp55 components of human cytomegalovirus. Virology 1992, 188:388-390. 10.1016/0042-6822(92)90771-G, 1314465.
12. Chou S. Molecular epidemiology of envelope glycoprotein H of human cytomegalovirus. J Infect Dis 1992, 166:604-607. 10.1093/infdis/166.3.604, 1323623.
13. Pachl C, Probert WS, Hermsen KM, et al. The human cytomegalovirus strain Towne glycoprotein H gene encodes glycoprotein p86. Virology 1989, 169:418-426. 10.1016/0042-6822(89)90167-0, 2539698.
14. Britt WJ. Neutralizing antibodies detect a disulfide-linked glycoprotein complex within the envelope of human cytomegalovirus. Virology 1984, 135:369-378. 10.1016/0042-6822(84)90193-4, 6330979.
15. Cranage MP, Kouzarides T, Bankier AT, et al. Identification of the cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinabt vaccination vires. EMBO J 1987, 5:3063-6057.
16. Rasmusses L, Mullenax J, Nelson R, Merigan TC. Viral polypeptides detected by a complet-dependent neutralizing murine monoclonal antibody to human cytomegalovirus. J Virol 1985, 55:274-280. 254930, 2410626.
17. Kari B, Lussenhop N, Goertz R, Wabuke-Bunoti M, Radeke R, Gehrz R. Characterization of monoclonal antibodies reactive to several biochemically distinct human cytomegalovirus glycoprotein complexes. J Virol 1986, 60:345-352. 288899, 3021969.
18. Banks T, Hou B, Kousoulas K, Spaete R, Pachl C, Pereira L. A major neutralizing domain maps within the carboxyl-terminal half of the cleaved cytomegalovirus B glycoprotein. J Gen Virol 1989, 70:979-985. 10.1099/0022-1317-70-4-979, 2471800.
19. Britt WJ, Vugler L, Butfiloski EJ, Stephens EB. Cell surface expression of human cytomegalovirus (HCMV) gp55-116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J Virol 1990, 64:1079-1085. 249220, 2154594.
20. Kniess N, Mach M, Fay J, Britt WJ. Distribution of linear antigenic sites on glycoprotein gp55 of human cytomegalovirus. J Virol 1991, 65:138-146. 240498, 1702157.
21. Urban M, Britt W, Mach M. The dominant linear neutralizing antibody-biding site of glycoprotein gp86 of human cytomegalovirus. J Virol 1992, 66:1303-1311. 240851, 1371164.
22. Qadri I, Navarro D, Paz P, Pereira L. Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus. J Gen Virol 1992, 73:2913-2921. 10.1099/0022-1317-73-11-2913, 1279102.
23. Basgoz N, Qadri I, Navarro D, et al. The amino terminus of human cytomegalovirus glycoprotein B contains epitopes that vary among strains. J Gen Virol 1992, 73:983-988. 10.1099/0022-1317-73-4-983, 1378884.
24. Keay S, Merigan TC, Rasmussen L. Identification of cell surface receptors for the 86-kilodalton glycoprotein of cytomegalovirus. Proc Natl Acad Sci USA 1989, 86:10100-10103. 10.1073/pnas.86.24.10100, 298652, 2557618.
25. Ljungman P. Prevention and treatment of viral infections in stem cell transplant recipients. Br J Haematol 2002, 118:44-57. 10.1046/j.1365-2141.2002.03515.x, 12100127.
26. Bonon SHA, Menoni SMF, Rossi CL, et al. Surveillance of cytomegalovirus infection in haematopoietic stem cell transplantation patients. J Infect 2005, 50:130-137. 10.1016/j.jinf.2003.11.010, 15667914.
27. Demmler GJ, Buffone GJ, Scimbor CM, May RA. Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification. J Infect Dis 1988, 158:1177-1184. 10.1093/infdis/158.6.1177, 2848897.
28. Shibata D, Martin WJ, Appleman MD, Causey DM, Leedom JM, Arnheim N. Detection of cytomegalovirus DNA in peripheral blood of patients infected with human deficiency virus. J Infect Dis 1988, 158:1185-1192. 10.1093/infdis/158.6.1185, 2848898.
29. Peres RMB, Costa CRC, Andrade PD, Bonon SHA, Albuquerque DM, et al. Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR. J Infect Dis 2010, 10:147-154.
30. Chakrabarti S, Mackinnon S, Chopra R, et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002, 99:4357-4363. 10.1182/blood.V99.12.4357, 12036862.
31. Yakushiji K, Gondo H, Kamezaki K, et al. Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction. Bone Marrow Transplant 2002, 29:599-606. 10.1038/sj.bmt.1703513, 11979310.
32. Machado CM, Dulley FL, Vilas Boas LS, et al. CMV pneumonia in allogeneic BMT recipients undergoing early treatment or pre-emptive ganciclovir therapy. Bone Marrow Transplant 2000, 26:413-417. 10.1038/sj.bmt.1702526, 10982288.
33. Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004, 14:383-410. 10.1002/rmv.438, 15386592.
34. Dieamant DC, Bonon SHA, Prates LC, Belangelo VMS, Pontes ER, Costa SCB. Active human cytomegalovirus infection and glycoprotein B genotypes in Brazilian pediatric renal or hematopoietic stem cell transplantation patients. Br J Microb 2010, 41:50-58.
35. Torok-Storb B, Boeckh M, Hoy C, et al. Association of specific cytomegalovirus genotypes with death from myelosuppression after marrow transplantation. Blood 1997, 90:2097-2102.
36. Nogueira E, Ozaki KS, Tomiyama H, et al. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients. Int Immunopharmacol 2009, 9:26-31. 10.1016/j.intimp.2008.08.020, 18824137.
37. Humar A, Kumar D, Gilbert C, et al. Cytomegalovirus (CMV) glycoprotein B genotypes and response to viral therapy, in solid-organ-transplant recipients with CMV disease. J Infect Dis 2003, 188:581-584. 10.1086/377002, 12898447.
38. Wu X, Wang Y, Xu Y, Wu D, Sun A, Zhu Z, et al. Cytomegalovirus glycoprotein B genotype in hematopoietic stem cell transplant patients from China. Biol Blood Marrow Transplant 2010, 16:647-652. 10.1016/j.bbmt.2009.12.001, 20025986.
39. Wu KG, Hung MC, Chang YT, Chen CJ, Yang SP, Liu CY, Ho DMT, Chan YJ. Occurrence of human cytomegalovirus glycoprotein B genotypes in immunocompetent and immunosuppressed Taiwanese patients. Intervirology 2011, 54:196-201. 10.1159/000322382, 21242663.
40. Coaquette A, Bourgeois A, Dirand C, et al. Mixed cytomegalovirus glycoprotein B genotypes in immunocompromised patients. Clin Infect Dis 2004, 39:155-161. 10.1086/421496, 15307021.
41. Halary F, Amara A, Lortat-Jacob H, et al. Human cytomegalovirus binding to DC-SING is required for dendritic cell infection and target cell trans-infection. Immunity 2002, 17:653-664. 10.1016/S1074-7613(02)00447-8, 12433371.
42. Yu ZS, Zou CC, Zheng JY, Zhao ZY. Cytomegalovirus gB genotype and clinical features in Chinese infants with congenital infections. Intervirology 2006, 49:281-285. 10.1159/000093458, 16714857.
43. Puchhammer-Stockl E, Gorzer I, Zoufaly A, et al. Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients. Transplantation 2006, 81:187-194. 10.1097/01.tp.0000194858.50812.cb, 16436961.
44. Cunha AA, Aquino VH, Mariquela V, Nogueira ML, Figueiredo LT. Evaluation of glycoprotein B genotype and load of CMV infecting blood leukocytes on prognosis of AIDS patients. Rev Inst Med Trop São Paulo 2011, 53:82-88.
45. Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jaedine AG, Humar A. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease. Clin Infect Dis 2009, 49:1160-1166. 10.1086/605633, 19751151.
46. Puchhammer-Stockl E, Gorzer I. Cytomelagovirus and Epstein-Barr virus subtypes the search for clinical significance. J Clin Virol 2006, 36:239-248. 10.1016/j.jcv.2006.03.004, 16697698.
47. Miller W, Flynn P, McCulbugh J, Balfour HH, Goldman A, Haake R. Cytomegalovirus infection after bone marrow transplantation: an association with acute graft-vs-host disease. Blood 1986, 67:1162-1167.
48. Martino R, Rovira M, Carreras E, et al. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD 34+ cell-selected transplantation. Haemat 2001, 86:1075-1086.
49. Ljungman P, Perez-Bercoff L, Jonsson J, et al. Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. Haemat 2006, 91:78-83.
50. Cunha AA, Aquino VH, Mariquela V, Nogueira ML, Figueiredo LT. Evaluation of glycoprotein B genotype and load of CMV infecting blood leukocytes on prognosis of AIDS patients. Rev Inst Med Trop Sao Paulo 2011, 53:82-88.
51. Appleton AL, Sviland L. Pathogenesis of GVHD: role of herpes viruses. Bone Marrow Transpl 1993, 11:349-355.